Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.106EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.41.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.109EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used